Posted in | News | Nanomedicine

NanoViricides to Participate on Nanomedicine Panel at NanoBusiness2010 Conference

From NanoViricides, IncSep 29 2010

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been invited to participate in a panel discussion on nanomedicines development at the NanoBusiness2010.

This event is taking place today at 2pm CDT at the 9th annual NanoBusiness Conference, held at the McCormick Place in Chicago, IL.

The panel, entitled “NanoMedicine: Science, Business and Regulatory Perspectives,” is composed of experts from Industry, Government, and Academia. It is chaired and moderated by Dr. Mostafa Analoui, Head of HealthCare and Life Sciences at the Livingston Securities, NY. Dr. Diwan will discuss the current developments at NanoViricides, Inc., and the opportunities and challenges in bringing our nanoviricide® drugs to market.

Source: http://www.nanoviricides.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
NanoViricides, Inc. (2019, February 13). NanoViricides to Participate on Nanomedicine Panel at NanoBusiness2010 Conference. AZoNano. Retrieved on April 21, 2025 from https://www.azonano.com/news.aspx?newsID=19747.
MLA
NanoViricides, Inc. "NanoViricides to Participate on Nanomedicine Panel at NanoBusiness2010 Conference". AZoNano. 21 April 2025. <https://www.azonano.com/news.aspx?newsID=19747>.
Chicago
NanoViricides, Inc. "NanoViricides to Participate on Nanomedicine Panel at NanoBusiness2010 Conference". AZoNano. https://www.azonano.com/news.aspx?newsID=19747. (accessed April 21, 2025).
Harvard
NanoViricides, Inc. 2019. NanoViricides to Participate on Nanomedicine Panel at NanoBusiness2010 Conference. AZoNano, viewed 21 April 2025, https://www.azonano.com/news.aspx?newsID=19747.